“Breath and Brain: When Sleep Apnea Signals Parkinson’s Danger”

In the stillness of the night, breathing should be restful — soft, rhythmic, and steady. But for millions, sleep is punctuated by gasps, pauses and suffocating silences. New research now suggests that this disturbed breathing may carry deeper risk than we once believed: untreated sleep apnea could be quietly raising the chances of developing Parkinson’s disease.

A major study led by researchers at Oregon Health & Science University (OHSU), using data from U.S. veterans over more than two decades, found that people with obstructive sleep apnea (OSA) faced a significantly higher risk of Parkinson’s. Even after adjusting for age, obesity, blood pressure and other factors, those who didn’t treat their sleep apnea with CPAP therapy were nearly twice as likely to be diagnosed with Parkinson’s.

Sleep apnea — where the airway collapses or narrows during sleep, causing repeated episodes of oxygen deprivation — is more than a nuisance. According to co-author Dr. Lee Neilson of OHSU, when oxygen levels dip and then rise night after night, year after year, neurons may suffer under this relentless stress. He notes that while the link doesn’t mean every person with sleep apnea will develop Parkinson’s, it suggests that treating the condition may help bolster resilience against neurodegeneration.

The study analyzed over 1.5 million veterans with diagnosed OSA and compared them with nearly 10 million without the disorder. After statistical adjustment, they estimated an extra 1.8 cases of Parkinson’s per 1,000 people in the group with untreated OSA over about five years. Crucially, those who started CPAP therapy within two years of their sleep apnea diagnosis tended to have a lower incidence of Parkinson’s than those who didn’t.

Why might CPAP — which simply keeps the airway open with mild positive pressure — offer protection? The researchers hypothesize that it could prevent recurring low-oxygen episodes, helping to preserve brain cells over time. If nightly breathing disruptions are the slow drip of a hidden risk, then CPAP could be a shield.

This is not the first clue linking sleep apnea and Parkinson’s. Earlier studies, including a large cohort in South Korea, have shown a bidirectional association: people with OSA had a higher risk of developing Parkinson’s, but also people diagnosed with Parkinson’s were more likely to develop sleep apnea. And research has documented that up to 45% of people with Parkinson’s show signs of obstructive sleep apnea — a surprisingly high prevalence.

But breathing doesn’t just impact risk; existing Parkinson’s patients may also benefit from treating apnea. A randomized controlled trial showed that using positive airway pressure (PAP) devices improved cognition in people with Parkinson’s over six months. The treated group saw better scores in cognitive tests, improvements in some non-motor symptoms, and even modest gains in motor function.

Despite these promising findings, researchers urge caution. This new data is preliminary, and while it highlights a strong association, it does not establish definitive causation. Some limitations exist — for example, the OHSU study could confirm who owned a CPAP device, but not how diligently they used it. More research is needed in diverse populations and with longer follow-up to fully understand how treating sleep apnea might influence Parkinson’s risk over a lifetime.

Still, the message from this work is quietly powerful: sleep health matters deeply, not just for day-to-day function, but for the long-term resilience of our nervous system. For those who breathe poorly at night, the solution may be more than rest — it could be prevention.

AI IMAGE DISCLAIMER “Visuals are AI-generated illustrations, meant for conceptual use only.”

SOURCES OHSU News American Academy of Neurology MedicalXpress HealthDay / Drugs.com Oxford Academic / SLEEP Journal